Chandan Healthcare Limited · NSE:CHANDAN
Chandan Healthcare — Investor Presentation (August 2025)
28 slides from Chandan Healthcare's investor presentation, Aug 21, 2025
Slide 1: Chandan Healthcare Limited Investor Presentation
Chandan Healthcare Limited Investor Presentation
Slide 2: Disclaimer
Disclaimer This presentation and the accompanying slides (the Presentation), which have been prepared by Chandan Healthcare (Chandan, The Company) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not
Slide 3: Company Overview
Company Overview Redefining Diagnostics & Pharmacy in North India Investor Presentation 3
Slide 4: Chandan at a Glance
Chandan at a Glance Chandan Healthcare Limited is one of the leading North India-based providers of diagnostic and pharmacy services, and a key entity within the Chandan Group. The Company offers a comprehensive suite of NABL/NABH-accredited pathology and radiology solutions across Uttar Pradesh and
Slide 5: Chandan Group of Companies
CHANDAN GROUP OF COMPANIES HOSPITALS DIAGNOSTICS PHARMACY PHAMACEUTICALS Cendana Chandan Healthcare Chandan Pharmacy Pharmaceuticals Private Chandan Hospital Chandan Super Speciality Limited Limited Limited Limited Limited Uttar Pradesh – 19 Cities Uttarakhand – 14 Cities Uttar Pradesh - 17 Cities L
Slide 6: Key Facts & Figures
Key Facts & Figures 1,496 + FY25 20+ 481 + Revenue: ₹ 232.17 Cr years of industry Pathology Tests Radiology Tests Offered EBITDA: ₹ 43.38 Cr expertise Offered PAT: ₹ 22.17 Cr 1300+ 18.21 lakh Total Patient Count Team Size (FY25) 360 D e ci si on ma ki ng i con 53.98 lakh + Collection Centres Total T
Slide 7: Key Events & Achievements
Key Events & Achievements Crossed turnover of ₹ 225 Cr 2025 Crossed turnover of ₹ 175 Cr 2025 2024 Started its first diagnostic centre in Dehradun 2013 Listed in Stock Exchange 2023 Crossed turnover of ₹ 125 Cr Incorporationof our Company in the 2003 name style of Chandan Healthcare Limited. 2003 St
Slide 8: Board Of Directors
Board Of Directors Amar Singh Asmita Singh Vinay Lamba Promoter, Chairman and Managing Director Promoter and Managing Director Non-Executive Director MBBS with 20+ years of experience in the BBA and MBA with 20+ years of marketing Marine Engineer with 10+ years of experience in healthcare industry e
Slide 9: Awards & Accolades
Awards & Accolades Most Innovative Healthcare Service Provider, 2018 ET Leadership Excellence Award-2024 Pride of India Awards Best Employer Brand 2018 India's Most Prominent Women Empowerment Awards 2019. Investor Presentation 9
Slide 10: Business Overview
Business Overview Multi-Segment Model Driving Growth Across B2C, B2B & B2G Investor Presentation 11
Slide 11: Balanced Business Model Across Retail, Government & Institutions
Balanced Business Model Across Retail, Government & Institutions Diversified revenue streams ensure stability, scalability, and reduced risk. B2C (Retail Diagnostics) B2B (Institutional Clients) B2G (Government PPPs) • Walk-inservices across 35+ • 230+ private hospitals & clinics as • Public-Private
Slide 12: Chandan's Core Business Verticals
Chandan’s Core Business Verticals Pathology Radiology Pharmacy FY25 Revenue FY25 Revenue FY25 Revenue ₹135.24 Cr ₹ 52.45 Cr ₹ 105.80 Cr (41.93%) (12.08%) (45.99%) Investor Presentation 12
Slide 13: State of the Art Pathology Laboratory
State of the Art Pathology Laboratory Pathology Radiology Investor Presentation 13
Slide 14: Chandan's Centre Network – Scale & Differentiation
Chandan’s Centre Network – Scale & Differentiation 6 8 21 Medium Large Centers Small Centers Centers Equipped with MRI & advanced Provide CT facilities, but no MRI; Basic healthcare & diagnostics imaging for comprehensive focus on essential imaging without MRI/CT; cater to Tier-2/3 diagnostics servi
Slide 15: Top Performing Centres Across Categories
Top Performing Centres Across Categories Large Medium Small Ayodhya, Rikabganj Lucknow, Indira Nagar Haldwani, Nainital Road Revenue – ₹ 8.43 Cr Revenue – ₹ 8.98 Cr Revenue – ₹ 2.36 Cr Customers Served – 85,904 Customers Served – 55,001 Customers Served – 25,324 Investor Presentation 15
Slide 16: Indian Diagnostics Sector Overview
Indian Diagnostics Sector Overview Market Size & Growth • Diagnostics industry expected to grow from US$13 Billion (FY23) to US$25 Billion Indian Diagnostic Market (US$ Billion) (FY28) at a 14% CAGR. • Growth driven by rising chronic diseases, ageing population, demand for preventive tests, and wide
Slide 17: Key Strengths Driving Sustainable Growth
Key Strengths Driving Sustainable Growth Integrated Diagnostic Platform Digital Ecosystem with Strong Adoption Offers 1,900+ pathology and radiology tests 100K+ downloads of Chandan 24x7 App under NABL/NABH-accredited infrastructure offering e-pharmacy, doctor consultations, test bookings, and digit
Slide 18: Expanding Footprint Across North & Central India
Expanding Footprint Across North & Central India Targeting high-growth Tier-2/3 and suburban markets Chandan Healthcare is expanding into six key cities across North and Central India, focusing on regions with growing demand for integrated diagnostics services. Expansion Highlights • New States: Ent
Slide 19: Financial Overview
Financial Overview Consistent Growth Backed by Scale, Efficiency & Expansion Investor Presentation 30
Slide 20: Financial Highlights
Financial Highlights Year On Year Revenue Growth Fixed Asset Turnover Interest Coverage Return on Equity 30.57% 2.86 Times 7.95 Times 27.08% Year on Year Profit Growth Return on capital Employed Debt to Equity Book Value 36.17% 29.34% 0.39 Times ₹ 50.14 Investor Presentation 20
Slide 21: Key Financial Highlights
Key Financial Highlights (All Amount In ₹ Cr & Margins In %) Total Income EBITDA EBITDA Margin PAT PAT Margin 232.17 43.38 22.17 18.69% 177.81 15.53% 16.28 27.62 137.03 6.95% 9.22% 9.63% 9.52 2.46% 3.37 FY23 FY24 FY25 FY23 FY24 FY25 FY23 FY24 FY25 The Company demonstrated exceptional financial growt
Slide 22: Profit & Loss Statement
Profit & Loss Statement (In ₹ Cr) Particulars FY23 FY24 FY25 Revenues 136.89 176.59 230.12 Other Income 0.14 1.2 2.0 2 5 Total Income 137.03 177.81 232.17 Raw Material Expenses 64.71 80.85 107.62 Employee Costs 25.49 35.42 38.86 Other Expenses 37.30 33.92 42.31 Total Expenditure 127.51 150.19 188.79
Slide 23: Balance Sheet
Balance Sheet (In ₹ Cr) Equities & Liabilities FY23 FY24 FY25 Assets FY23 FY24 FY25 Equity 20.00 20.00 24.45 Non-Current Assets Reserves And Surplus 2.76 21.16 98.15 Fixed assets 32.56 48.49 80.45 Total Equity 22.76 41.16 122.60 Non-Current Investments 4.54 3.38 1.15 Non-Current Liabilities Other No
Slide 24: Key Ratios
Key Ratios (In %) ROCE (In %) ROE 47.60% 35.04% 29.34% 15.51% 27.08% 13.15% FY23 FY24 FY25 FY23 FY24 FY25 (In Times) Interest Coverage 8.7 7.95 0.78 3.03 FY23 FY24 FY25 Investor Presentation 24
Slide 25: Key Ratios
Key Ratios (In ₹) (In ₹) Earnings Per Share Book Value 50.14 10.78 8.14 20.58 15.03 1.68 FY23 FY24 FY25 FY23 FY24 FY25 Investor Presentation 25
Slide 26: Stock Data
Stock Data As On 21-08-2025 As On 31-03-2025 NSE (SSEGL | INE0RFP01011) Share Holding Pattern Share Price (₹) 238.00 Market Capitalization (₹ Cr) 581.96 50.57% Promoter & Promoter Group No. of Shares Outstanding 2,44,52,064 Public Face Value (₹) 10.00 49.43% 279.00 – 140.00 52-week High-Low (₹) Shar
Slide 27: Investor Rationale
Investor Rationale Volume-Led Growth Widespread Presence Strategy with a with operations across scalable model Experienced Promoter- 44+ cities in 8 states, anchored in in-house Led Team with 20+ enabling deep regional labs, B2B referral years in healthcare penetration and first- partnerships, and l
Slide 28: Thank You
Thank You Address: Chandan Healthcare Ltd. Biotech Park, Kursi Road, Lucknow 226021 U.P. Email: care@chandan.co.in Phone: 08069366666 Website: www.chandandiagnostic.com Dr. Amar Singh (Chairman and MD) Mr. Rajeev Nain (Chief Financial Officer )
Chandan Healthcare — Investor Presentation (August 2025) on 6ix